3 completed, 1 not yet recruiting, 1 recruiting. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Migraine without Aura: new trials by email Literature Review of Migraine without Aura trials Research Report on Migraine without Aura
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Prospective, Open-Label Study Evaluating the Effectiveness of Gepants for Acute Treatment of Migraine in the Emergency Department Rimegepant, Zavegepant - Migraine, Migraine Disease | Phase 1 | Recruiting | University of South Florida | 100 | 2026-09-15 | 2026-10-27 |
| Efficacy and Mechanism of Fu's Subcutaneous Needling Treatment for Migraine Without Aura Fu's Subcutaneous Needling, Flunarizine Hydrochloride - Migraine Without Aura | Phase 1 | Not yet recruiting | Guangzhou University of Chinese Medicine | 60 | 2025-09-01 | 2025-07-16 |
| A Study of the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects Dihydroergotamine - Migraine, Migraine With Aura | Phase 1 | Completed | Satsuma Pharmaceuticals, Inc. | 36 | 2021-03-05 | 2022-04-20 |
| A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects Dihydroergotamine - Migraine With Aura, Migraine Without Aura | Phase 1 | Completed | Satsuma Pharmaceuticals, Inc. | 46 | 2018-09-11 | 2019-11-26 |
| Botox Injection in Treatment of Chronic Migraine Botulinum Toxin Type A - Migraine Disorders | Phase 1 / Phase 2 | Completed | Norwegian University of Science and Technology | 10 | 2015-02-01 | 2016-05-23 |
Migraine Disorders (4) · Migraine with Aura (4) · Headache Disorders (1)
Brain Diseases (5) · Central Nervous System Diseases (5) · Headache Disorders, Primary (5) · Nervous System Diseases (5) · Headache Disorders (4) · Migraine Disorders (1)
Dihydroergotamine (2) · Botulinum Toxins, Type A (1) · Flunarizine (1) · rimegepant sulfate (1)
Satsuma Pharmaceuticals, Inc. (2) · Guangzhou University of Chinese Medicine (1) · Norwegian University of Science and Technology (1) · University of South Florida (1)
United States (3) · Norway (1)
Erling A Tronvik, PhD, MD (1) · Jeffrey A Levy, MD, PhD (1) · Jeffrey Levy, MD (1) · Jian Sun, M.D. (1)
PMID 27154997, PMID 31985049, PMID 38413540
2014 (1)